These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10440213)
21. Ca(2+)-calmodulin antagonist chlorpromazine and poly(ADP-ribose) polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of BCL-XL and P53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice. Ray SD; Balasubramanian G; Bagchi D; Reddy CS Free Radic Biol Med; 2001 Aug; 31(3):277-91. PubMed ID: 11461765 [TBL] [Abstract][Full Text] [Related]
22. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Su SJ; Chow NH; Kung ML; Hung TC; Chang KL Nutr Cancer; 2003; 45(1):113-23. PubMed ID: 12791511 [TBL] [Abstract][Full Text] [Related]
23. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Fernández Y; España L; Mañas S; Fabra A; Sierra A Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Taylor JK; Zhang QQ; Monia BP; Marcusson EG; Dean NM Oncogene; 1999 Aug; 18(31):4495-504. PubMed ID: 10442640 [TBL] [Abstract][Full Text] [Related]
25. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it. Rashmi R; Kumar S; Karunagaran D Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359 [TBL] [Abstract][Full Text] [Related]
26. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609 [TBL] [Abstract][Full Text] [Related]
27. Expression of bcl-xL can confer a multidrug resistance phenotype. Minn AJ; Rudin CM; Boise LH; Thompson CB Blood; 1995 Sep; 86(5):1903-10. PubMed ID: 7655019 [TBL] [Abstract][Full Text] [Related]
28. Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression. Takeda Y; Nakao K; Nakata K; Kawakami A; Ida H; Ichikawa T; Shigeno M; Kajiya Y; Hamasaki K; Kato Y; Eguchi K Jpn J Cancer Res; 2001 Sep; 92(9):918-25. PubMed ID: 11572758 [TBL] [Abstract][Full Text] [Related]
29. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840 [TBL] [Abstract][Full Text] [Related]
30. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971 [TBL] [Abstract][Full Text] [Related]
31. Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-XL succeeds bcl-2 function in neoplastic cells. Crescenzi E; Criniti V; Pianese M; Tecce MF; Palumbo G Gynecol Oncol; 2000 Jun; 77(3):419-28. PubMed ID: 10831353 [TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis by transforming growth factor-beta 1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Fukuda K; Kojiro M; Chiu JF Hepatology; 1993 Oct; 18(4):945-53. PubMed ID: 7691707 [TBL] [Abstract][Full Text] [Related]
33. [Bcl-xl blocks tumor necrosis factor alpha-induced caspase 8 activation and apoptosis]. Yang L; Deng YB; Wu XW Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):286-9. PubMed ID: 15850519 [TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xL. Dai Y; Dent P; Grant S Mol Pharmacol; 2003 Dec; 64(6):1402-9. PubMed ID: 14645670 [TBL] [Abstract][Full Text] [Related]
35. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes. Rohrbach S; Muller-Werdan U; Werdan K; Koch S; Gellerich NF; Holtz J J Mol Cell Cardiol; 2005 Mar; 38(3):485-93. PubMed ID: 15733908 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of the dexamethasone effect on alpha-fetoprotein gene expression in McA-RH8994 rat hepatoma cells. Cook JR; Chiu JF J Biol Chem; 1986 Apr; 261(10):4663-8. PubMed ID: 2420790 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration. Joseph RM; Li T Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2434-46. PubMed ID: 8933760 [TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis. Esche C; Shurin GV; Kirkwood JM; Wang GQ; Rabinowich H; Pirtskhalaishvili G; Shurin MR Clin Cancer Res; 2001 Mar; 7(3 Suppl):974s-979s. PubMed ID: 11300499 [TBL] [Abstract][Full Text] [Related]
39. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Huang DC; Cory S; Strasser A Oncogene; 1997 Jan; 14(4):405-14. PubMed ID: 9053837 [TBL] [Abstract][Full Text] [Related]
40. 'Loop' domain deletional mutant of Bcl-xL is as effective as p29Bcl-xL in inhibiting radiation-induced cytosolic accumulation of cytochrome c (cyt c), caspase-3 activity, and apoptosis. Burri SH; Kim CN; Fang G; Chang BS; Perkins C; Harris W; Davis LW; Thompson CB; Bhalla KN Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):423-30. PubMed ID: 10030271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]